Phthisis Diagnostics Announces First International Distribution Agreement
News May 25, 2012
Phthisis Diagnostics, Inc. has announced the signing of its first distribution agreement for international sales. Bio Products, Inc. will distribute the company’s Simply Molecular® product line throughout Latin America.
Bio Products, Inc. is a privately held American company established in West Palm Beach, Florida, over two decades ago.
The company has built a reputation for representing a large number of prestigious manufacturers and distributors to serve the research, medical, and scientific community throughout Latin America.
Phthisis Diagnostics President and Chief Science Officer Crystal Icenhour, PhD, commented, “We are delighted to welcome Bio Products as our first distributor for international sales. This is an important next step in the development of Phthisis Diagnostics. We are currently engaged in negotiations and look forward to announcing additional international distribution agreements soon.”
Biomarkers Could Produce Preeclampsia Diagnostic TestNews
Small non-coding RNA analysis may revolutionize how doctors assess preeclampsia risk.READ MORE
Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease DiagnosisNews
The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.READ MORE
Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast CancerNews
A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.READ MORE